Singapore markets close in 7 hours 42 minutes
Straits Times Index
3,306.69 +14.00 (+0.43%) Nikkei
38,174.75 -99.30 (-0.26%) Hang Seng
17,763.03 0.00 (0.00%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,758.70 -2,084.02 (-3.48%) CMC Crypto 200
1,266.87 -72.20 (-5.39%)
ABT May 2024 122.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 11:22AM EDT. Market open.
| Previous close | 0.0200 |
| Open | 0.0200 |
| Bid | 0.0000 |
| Ask | 0.8200 |
| Strike | 122.00 |
| Expiry date | 2024-05-03 |
| Day's range | 0.0200 - 0.0200 |
| Contract range | N/A |
| Volume | |
| Open interest | 3 |
ZacksIs Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
ZacksPBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR NewswireAbbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
© 2024 Yahoo. All rights reserved.